NIM
GMAB icon

NEOS Investment Management’s Genmab GMAB Stock Holding History

NEOS Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-140,733
Closed -$4.33M – 605
2025
Q4 		$4.33M Buy
140,733
+8,690
+7% +$271K 0.03% 349
2025
Q3 		$4.05M Buy
132,043
+1,826
+1% +$44.5K 0.03% 333
2025
Q2 		$2.69M Buy
130,217
+27,468
+27% +$564K 0.03% 326
2025
Q1 		$2.01M Buy
102,749
+24,066
+31% +$505K 0.04% 321
2024
Q4 		$1.64M Buy
78,683
+37,533
+91% +$825K 0.04% 326
2024
Q3 		$1M Buy
41,150
+2,596
+7% +$69.4K 0.03% 375
2024
Q2 		$969K Buy
38,554
+26,246
+213% +$744K 0.04% 333
2024
Q1 		$368K Buy
12,308
+362
+3% +$10.6K 0.02% 453
2023
Q4 		$380K Buy
+11,946
New +$375K 0.04% 334

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

NEOS Investment Management's GMAB Position: Q1 2026 in Review

NEOS Investment Management sold out of Genmab (GMAB) in Q1 2026, closing a stake of 140,733 shares — an estimated $4.33M sold.

NEOS Investment Management first reported a position in GMAB in Q4 2023 and held it in 9 quarters. The position peaked at $4.33M in Q4 2025. 275 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • NEOS Investment Management reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 140,733 Genmab shares in Q1 2026, an estimated $4.33M.
  • NEOS Investment Management first reported a position in Genmab in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Genmab position peaked at $4.33M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.